CEO: Ryan J. Watts

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.


Key numbers

Market Capitalization:1453909340
Shares Outstanding: 96031000
Float: 66594425.508
Next Earning Date:2020-03-10
TTm EPS: -0.6818
TTm Dividend Rate:
200 days moving average:19.93
50 days moving average: 16.21
One day percent Change: 9.97



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,